AFJK

Business Context and Reporting Period

Aimei Health Technology Co., Ltd. (AFJK) is a Cayman Islands exempted company and a blank check entity (SPAC) formed on April 27, 2023. The company intends to pursue a business combination with healthcare innovation targets, specifically in biopharmaceuticals, medical technology, and diagnostics. As of the reporting date, the company has not commenced any operations; all activities relate to its formation, Initial Public Offering (IPO), and evaluation of business combination candidates.

Reporting Period: Quarterly period ended September 30, 2024.

Key Status: The company is classified as a shell company, a smaller reporting company, and an emerging growth company. On June 19, 2024, the company entered into a definitive Business Combination Agreement with United Hydrogen Group Inc.

Key Financial Metrics

Material Changes vs. Prior Period

• Profitability Shift: The company reported a net income of $743,510 for the three months ended September 30, 2024, compared to $0 for the same period in 2023. This is primarily driven by interest income of $943,529 earned on the Trust Account, offset by formation and operating costs of $200,019.
• Trust Account Growth: The Trust Account balance increased from $69,889,848 as of December 31, 2023, to $72,660,715 as of September 30, 2024, due to interest earnings on U.S. Treasury securities.
• Liquidity Position: Operating cash decreased from $580,717 at year-end 2023 to $103,559 at September 30, 2024, reflecting the use of funds for operating expenses and administrative costs.
• Liabilities: Current liabilities increased to $230,789 from $24,841 in the prior year, driven by accrued expenses and amounts due to a related party ($88,763) for administrative services.

Outlook, Risks, and Management Commentary

• Business Combination: The company has signed a definitive agreement to merge with United Hydrogen Group Inc. The transaction is subject to shareholder approval and other customary closing conditions. The agreement includes a termination date of March 31, 2025, if conditions are not met.
• Liquidity and Going Concern: Management has identified substantial doubt about the company's ability to continue as a going concern if a business combination is not consummated within the prescribed period (initially 12 months, extendable to 24 months). If no combination occurs, the company will liquidate and redeem public shares.
• Capital Resources: The company relies on funds held outside the Trust Account ($103,559) for operations. The Sponsor or affiliates may provide "Working Capital Loans" to finance transaction costs, though none were outstanding as of September 30, 2024.
• Internal Controls: Management concluded that disclosure controls and procedures were not effective as of September 30, 2024.
• Deferred Compensation: The company owes $690,000 in deferred underwriting commissions, payable only upon the successful closing of a business combination.

Investor Verification Checklist

• Merger Status: Verify the current status of the proposed business combination with United Hydrogen Group Inc. and the likelihood of shareholder approval.
• Going Concern Risk: Assess the timeline for closing the merger against the 24-month deadline to avoid forced liquidation.
• Redemption Rights: Confirm the redemption value per share ($10.53 as of Sept 30, 2024) and the potential impact of mass redemptions on the deal's viability.
• Internal Controls: Review the specific deficiencies cited regarding the ineffectiveness of disclosure controls and procedures.
• Related Party Obligations: Monitor the $88,763 owed to the related party for administrative services and any potential future Working Capital Loans.